Conversely, a comprehensive RNA-based molecular profiling revealed a cryptic e13a2 BCR-ABL1 rearrangement, changing the patient diagnosis into CML. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.